Newsfiscal.ai
B. Riley Securities Raises Price Target on PDS Biotechnology to $4
· Published
Article summary
B. Riley Securities has maintained its 'Buy' rating on PDS Biotechnology while increasing the price target from $3 to $4.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…